Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy

TA Patente, MP Pinho, AA Oliveira… - Frontiers in …, 2019 - frontiersin.org
Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve
T cell activation and effector differentiation. They are, likewise, involved in the induction and …

Interleukin-1 as innate mediator of T cell immunity

B Van Den Eeckhout, J Tavernier, S Gerlo - Frontiers in immunology, 2021 - frontiersin.org
The three-signal paradigm tries to capture how the innate immune system instructs adaptive
immune responses in three well-defined actions:(1) presentation of antigenic peptides in the …

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

J Galon, HK Angell, D Bedognetti, FM Marincola - Immunity, 2013 - cell.com
Numerous analyses of large patient cohorts identified specific patterns of immune activation
associated with patient survival. We established these as the immune contexture …

Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function

M Reis, E Mavin, L Nicholson, K Green… - Frontiers in …, 2018 - frontiersin.org
Mesenchymal stromal cells (MSCs) are potent regulators of immune responses largely
through paracrine signaling. MSC secreted extracellular vesicles (MSC-EVs) are …

The effect of short-chain fatty acids on human monocyte-derived dendritic cells

C Nastasi, M Candela, CM Bonefeld, C Geisler… - Scientific reports, 2015 - nature.com
The gut microbiota is essential for human health and plays an important role in the
pathogenesis of several diseases. Short-chain fatty acids (SCFA), such as acetate, butyrate …

Dendritic cell therapy in cancer treatment; the state-of-the-art

M Sadeghzadeh, S Bornehdeli… - Life sciences, 2020 - Elsevier
Dendritic cells (DCs) are considered as professional antigen presenting cells (APCs),
containing a variety of subsets, that can be resident in organs or migrating among the …

Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice

B Zuo, H Qi, Z Lu, L Chen, B Sun, R Yang… - Nature …, 2020 - nature.com
Treating large established tumors is challenging for dendritic cell (DC)-based
immunotherapy. DC activation with tumor cell-derived exosomes (TEXs) carrying multiple …

Moving on from sipuleucel-T: new dendritic cell vaccine strategies for prostate cancer

SIM Sutherland, X Ju, LG Horvath, GJ Clark - Frontiers in immunology, 2021 - frontiersin.org
Tumors evade the immune system though a myriad of mechanisms. Using checkpoint
inhibitors to help reprime T cells to recognize tumor has had great success in malignancies …

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients

J Adamik, PV Munson, DM Maurer… - Nature …, 2023 - nature.com
Efficacy of cancer vaccines remains low and mechanistic understanding of antigen
presenting cell function in cancer may improve vaccine design and outcomes. Here, we …

Engineered cell membrane‐derived nanoparticles in immune modulation

Y Yang, K Wang, Y Pan, L Rao, G Luo - Advanced Science, 2021 - Wiley Online Library
Immune modulation is one of the most effective approaches in the therapy of complex
diseases, including public health emergency. However, most immune therapeutics such as …